secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2025-08-22T23:59:59+00:00
Accession:  0000950170-25-110952
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invivyd closes $57.5M public offering; net proceeds ~$53.5M for pipeline development
--------------------------------------------------------------------------------

- Raised ~$57.5M gross ($53.5M net) via 89.2M shares at $0.52/sh and 21.3M pre-funded warrants at $0.5199.
- Underwriters' full option exercised; offering led by RA Capital Management and Janus Henderson.
- Proceeds to fund VYD2311 clinical program, RSV/measles R&D, and Long COVID studies (SPEAR Study Group).
- Dilution: total shares outstanding increases by ~110.6M (including pre-funded warrants exercisable).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000095017025110952/0000950170-25-110952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000095017025110952/ivvd-20250820.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-110952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer